Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
AbCellera and Lilly to Co-develop Antibody Therapies for the Treatment of COVID-19
Friday, March 13, 2020AbCellera and Eli Lilly and Company announced they have entered into an agreement to codevelop antibody products for the treatment and prevention of COVID the disease caused by the SARSCoV novel coronavirus The collaboration will leverage AbCelleras...
Tyligand Bioscience and Context Therapeutics Sign Strategic Development Agreement for Onapristone ER
Friday, March 13, 2020Tyligand Bioscience Ltd a leader in small molecule drug discovery and development and Context Therapeutics LLC a clinical stage biopharmaceutical company focused on hormone driven cancers today announced the signing of collaboration agreements for th...
Vir Biotechnology Announces Research Collaboration with the National Institutes of Health Vaccine Research Center on Antibodies Against Coronaviruses
Thursday, March 12, 2020Vir Biotechnology Inc announced a research collaboration agreement with the National Institutes of Health NIH and the National Institute of Allergy and Infectious Diseases NIAID Vaccine Research Center VRC to advance characterization and development...
IDEAYA Biosciences and Cancer Research UK Announce Expanded Research Collaboration for PARG, a DDR-Based Synthetic Lethality Target, Evaluating DNA Replication Vulnerabilities
Thursday, March 12, 2020IDEAYA Biosciences Inc an oncologyfocused precision medicine company committed to the discovery and development of targeted therapeutics to treat cancer announced an expanded research collaboration with Cancer Research UK and the University of Manche...
Phio Pharmaceuticals and Helmholtz Zentrum München Announce Collaboration and Option Agreement with Medigene
Wednesday, March 11, 2020Phio Pharmaceuticals Corp a biotechnology company developing the next generation of immunooncology therapeutics based on its proprietary selfdelivering RNAi INTASYL therapeutic platform today announced that it has reached a new agreement with Medigen...
Emergent BioSolutions Signs Development and Manufacturing Agreement With Novavax for Experimental Vaccine Candidate for Coronavirus Disease
Wednesday, March 11, 2020Emergent BioSolutions Inc announced that it has entered into an agreement with Novavax Inc NASDAQNVAX whereby Emergent will collaborate with Novavax utilizing its moleculetomarket contract development and manufacturing CDMO services to support bringi...
Zydus and XOMA Announce IL-2-Based Immuno-Oncology Therapy Licensing Agreement
Tuesday, March 10, 2020Zydus Cadila an innovationdriven global pharmaceutical company and XOMA Corporation announced they have entered into a licensing agreement to advance an ILbased immunooncology IO drug candidate that combines Zydus IL with XOMAs novel antiIL monoclona...
Bridge Biotherapeutics Enters AI-based Research Collaboration with Atomwise to Expand Pellino Inhibitor Pipeline
Tuesday, March 10, 2020Atomwise the leader in using artificial intelligence AI for small molecule discovery and Bridge Biotherapeutics a clinical stage biotech company announced today a research collaboration to launch up to small molecule programs across multiple therape...
Nanoform and Orion Collaborate on Next-generation Drug Development
Monday, March 09, 2020Nanoform an innovative nanoparticle medicine enabling company and Orion Corporation a Finnish pharmaceutical company today announced a collaboration to apply Nanoforms awardwinning CESS technology to new chemical entities Building on an existing rela...
Mount Sinai and Harbour BioMed Collaborate to Advance Novel Biotherapies for the Treatment of Cancer and Coronavirus COVID-19
Saturday, March 07, 2020Mount Sinai Health System and Harbour BioMed HBM have entered into a multiyear multifaceted collaboration to develop novel fully human antibodies for the treatment and prevention of various diseases including oncology and immunology
